Back to dashboard
Episode 82
DIP Episode 82 - USMLE Step 1 Hematology Review Part 4 (Oncology)
MixedMedium4 - HighHas Q&A
Step 1Step 2Step 3MedicineUSMLEStep 1Step 2Step 3
Topic
Lymphoma and Leukemia Classification; Lymph Node Anatomy & Metastasis Patterns; Hematologic Malignancies (Burkitt's, Follicular, MCL)...
Key Takeaway
The distinction between the translocation, cell markers (CD20/CD5/CD23), and clinical presentation is critical for differentiating specific B-cell lymphomas (e.g., Burkitt's vs. Follicular vs. MCL) and understanding the progression from chronic to acute leukemias.
Runtime: 42.8 min
Published: 2019-02-25
Completed audio: Yes
Completed notes: Yes
Anki made: Yes
Section: HEME-ONC
Episode Notes
Source / episode info
- Episode: 82
- Title: Divine Intervention Episode 82 – USMLE Step 1 Hematology Review Part 4 (Oncology)
- Published: 2019-02-25
- Source: Episode page
One-liner
This episode reviews key concepts in hematopathology, covering lymph node anatomy (paracortex/follicles), common metastatic patterns, and detailed comparisons of B-cell lymphomas (Burkitt's, Follicular, MCL) and leukemias (CLL, Hairy Cell), emphasizing specific translocations and immunophenotypes.
High-yield summary
- Lymph Node Architecture: In response to bacterial infection, the germinal follicles show follicular hyperplasia with well-demarcated architecture; this is distinct from a true lymphoma where the node architecture is effaced by neoplastic cells.
- Bimodal Age Distribution: Hodgkin Lymphoma (HL) classically presents in two peaks: young adulthood (15–34 years) and older age (>50 years).
- Translocation Signatures: Burkitt's Lymphoma involves t(8;14) leading to c-MYC overexpression. Follicular Lymphoma involves t(14;18) leading to BCL2 overexpression. Mantle Cell Lymphoma (MCL) involves t(11;14) leading to Cyclin D1 overexpression.
- Immunophenotype Differentiation: CLL is CD5+ and CD23+. MCL is CD5+ but lacks CD23 expression. T-cell lymphomas are typically positive for CD3, CD5, CD7.
- Clinical Pearls: The classic triad for Hairy Cell Leukemia includes massive splenomegaly, hepatosplenomegaly, and a "dry tap" on bone marrow aspiration.
- Metastatic Patterns: Left supraclavicular lymphadenopathy (varicose node) suggests abdominal/GI tract malignancy; right supraclavicular suggests lung or GI malignancy.
Learning objectives
- Differentiate between follicular hyperplasia and true lymphoma based on nodal architecture preservation.
- Identify the characteristic translocations (t(8;14), t(14;18), t(11;14)) associated with major B-cell lymphomas.
- Recognize the key clinical presentations and markers for CLL, MCL, and Hairy Cell Leukemia.
- Apply knowledge of lymph node drainage patterns to localize metastatic primary cancers (e.g., left vs right supraclavicular).
- Understand the difference between T-cell and B-cell lineage markers in lymphoma diagnosis.
Board exam buzzwords
| Condition | Key Finding | Association | Board Exam Tip |
| Burkitt's Lymphoma | Starry sky pattern; t(8;14) translocation | EBV, c-MYC overexpression | Remember the GI type is common in Americans/Europeans. |
| Follicular Lymphoma | Effaced architecture; t(14;18) translocation | BCL2 overexpression | The hallmark is the overexpression of BCL2 leading to slow growth. |
| Mantle Cell Lymphoma (MCL) | CD5+ positive, but CD23 negative; t(11;14) translocation | Cyclin D1 overexpression | This combination (CD5+/CD23-) is the most reliable way to distinguish MCL from CLL. |
| Hairy Cell Leukemia | Dry tap on bone marrow aspiration; massive splenomegaly | CD11c+ positive cells | The triad of findings (splenomegaly, dry tap) is highly suggestive. |
Rapid review table
| Topic | Key Point | Context | Exam Relevance |
| Lymph Node Anatomy | B-cells in follicles; T-cells in paracortex/PALS | LN structure and immune response | Knowing the anatomical location helps localize primary sites of infection or malignancy. |
| Hodgkin Lymphoma (HL) | Bimodal age distribution (15–34 & >50 years) | Classic demographic pattern | Use this concept to link HL with other bimodal distributions (e.g., isoniazid/fast-acting learners). |
| CLL vs MCL | CLL: CD23+; MCL: CD23- | Immunophenotyping | This is a classic trap question used to differentiate two common B-cell malignancies. |
| Acute Leukemias | >20% blasts in bone marrow | Diagnosis of acute leukemia | The blast percentage threshold (20%) is the critical diagnostic cutoff for acute vs chronic phase. |
Board-speak -> diagnosis
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A patient with a history of Hashimoto's thyroiditis presents with an enlarging, suspicious thyroid mass. | Thyroid Lymphoma (MAL Toma) | Autoimmune predisposition (Hashimoto's) is the biggest risk factor for developing lymphoma in this site. |
| An immunocompromised patient develops lymphadenopathy and biopsy shows neoplastic B-cells with a "starry sky" pattern. | Burkitt's Lymphoma | The starry sky appearance is pathognomonic, and EBV/t(8;14) are key associations. |
| A 65-year-old man presents with generalized lymphadenopathy and peripheral blood smear shows small, smudge cells. | Chronic Lymphocytic Leukemia (CLL) | CLL is the most common adult leukemia, characterized by smudges and typically found in older populations. |
| Biopsy of a lymph node reveals B-cell proliferation where the normal follicular structure remains intact but enlarged. | Follicular Hyperplasia | The key distinction from lymphoma is the preservation of the overall nodal architecture (hyperplasia vs effacement). |
| A young male presents with an anterior mediastinal mass and T-cell markers are positive on flow cytometry. | T-Cell Lymphoma | Anterior mediastinum, especially in a young patient, suggests thymic/T-cell origin; CD3/CD5/CD7 positivity confirms this lineage. |
| A lymph node biopsy shows B-cells with an abnormal nuclear chromatin pattern and the cells are positive for CD10 and CD20. | Follicular Lymphoma (or general B-cell lymphoma) | The combination of specific markers and the translocation t(14;18) defines this group, often presenting as a slow-growing mass. |
Differential diagnosis / distinguishing features
CLL vs. MCL
| Key Features | Distinguishing Findings | Next Step |
| Both are B-cell malignancies; both can be CD5+. | CLL: Positive for CD23. MCL: Negative for CD23 (but positive for Cyclin D1/t(11;14)). | Flow cytometry panel to determine the presence or absence of CD23. |
Hairy Cell Leukemia vs. Primary Myelofibrosis
| Key Features | Distinguishing Findings | Next Step |
| Massive splenomegaly, dry tap on aspiration, characteristic "hairy" cells (CD11c+). | Hairy Cells: Specific morphology and CD11c positivity. PMF: Often presents with tear-drop shaped RB Cs; bone marrow shows reticulin fibrosis. | Bone marrow biopsy/Aspiration for morphologic confirmation and flow cytometry. |
Management pearls
- For suspected lymphadenopathy from GI sources (e.g., stomach, pancreas), always consider the possibility of a MAL Toma or other localized lymphoma, especially if associated with H. pylori infection.
- The presence of a "dry tap" on bone marrow aspiration is highly suggestive of primary myelofibrosis or CLL/hairy cell leukemia and warrants further investigation for underlying marrow pathology.
- When evaluating lymphadenopathy, always correlate the location (e.g., left vs right supraclavicular) with potential distant primary sites to narrow the differential diagnosis.
Don't miss
🚨
Left Supraclavicular Node: Think abdominal/GI tract sources (stomach, pancreas). This is often called a "varicose node."
🚨
Right Supraclavicular Node: Think lung or GI sources.
🚨
T-Cell Lymphoma Markers: When T-cell lineage is suspected, look for CD3, CD5, and CD7 positivity, especially in the context of an anterior mediastinal mass in a young patient.
Integration & clinical reasoning
- Immunology Connection: The concept of follicular hyperplasia (reactive B-cell proliferation) directly relates to secondary immune responses following infection, which contrasts sharply with the primary neoplastic process seen in lymphoma.
- Oncology/GI Link: H. pylori is not just associated with peptic ulcers; it can be a direct cause of MAL Toma, illustrating how chronic inflammation leads to malignancy.
Concept connections / cross-references
- For detailed review on immunopharmacology and monoclonal antibodies (e.g., Rituximab), see the podcast discussing anti-CD20 agents.
- The general principles of lymph node anatomy are covered in foundational immunology reviews [Episode 37].
High-yield association table
| Condition | Association | Mechanism | Clinical Significance |
| Burkitt's Lymphoma | t(8;14) translocation | Overexpression of c-MYC oncogene | Highly aggressive B-cell lymphoma, often associated with EBV. |
| Follicular Lymphoma | t(14;18) translocation | Overexpression of BCL2 anti-apoptotic gene | Slow-growing NHL that can progress to DLBCL. |
| Mantle Cell Lymphoma (MCL) | t(11;14) translocation | Overexpression of Cyclin D1 protein | Leads to uncontrolled cell cycle progression, making it a distinct and aggressive B-cell malignancy. |
| Hairy Cell Leukemia | Bone marrow dry tap; massive splenomegaly | CD11c+ cells with "hairy" projections | Classic triad makes this diagnosis highly probable on board exams. |
Key terms glossary
| Term | Definition | Context | Example |
| Paracortex | The T-cell rich region of a lymph node. | Lymph Node Anatomy | Site where T-cells are primarily housed and activated. |
| Varicose Node | Left supraclavicular lymphadenopathy. | Metastatic Patterns | Suggests primary malignancy originating from the abdominal cavity (e.g., stomach, pancreas). |
| t(14;18) | Chromosomal translocation between chromosomes 14 and 18. | Follicular Lymphoma Genetics | Results in BCL2 overexpression, promoting cell survival. |
| CD23 | A surface marker protein on lymphocytes. | Immunophenotyping | Positive expression helps distinguish CLL from MCL. |
Study optimization
| Topic | Study Approach | Priority | Resources |
| Lymphoma Translocations | Memorize the translocation and the resulting oncogene/protein overexpression (e.g., t(8;14) -> c-MYC). | High | Flow cytometry panels, pathology slides review. |
| Leukemia Differentials | Create a comparison table for CLL vs MCL vs Hairy Cell Leukemia based on markers and clinical findings. | Medium-High | Review board questions focusing on immunophenotyping traps. |
| Lymph Node Drainage | Visualize the body's lymphatic pathways, paying special attention to supraclavicular nodes. | Medium | Clinical correlation with primary cancer sites (e.g., left vs right). |
Question pattern recognition
- Translocation/Oncogene Association: Linking a specific chromosomal abnormality (t(X;Y)) to an overexpressed oncogenic protein is a high-yield pattern in hematopathology.
- Differential Diagnosis by Marker: Using flow cytometry markers (CD23, CD5) to distinguish between two similar-looking malignancies (CLL vs MCL).
- Clinical Triad Recognition: Identifying classic constellations of symptoms/signs (e.g., splenomegaly + dry tap for Hairy Cell Leukemia).
Test yourself
Common mistakes to avoid
🚫
Mistaking follicular hyperplasia (reactive process) for true lymphoma (neoplastic effacement). Always assess the architecture!
🚫
Assuming that all lymphadenopathy is due to infection; always consider metastatic spread or primary malignancy.
🚫
Confusing the markers of CLL and MCL; remember CD23 positivity points strongly toward CLL.
Common traps
⚠️
The "Varicose Node" Trap: If the node is left supraclavicular, think abdominal/GI sources (stomach/pancreas). If it's right, think lung/GI.
⚠️
CLL vs MCL Marker Trap: The most common mistake is confusing CD23 status; remember CLL = CD23+.
⚠️
Age Distribution Trap: Do not assume that because a patient is old, they have CLL; always consider other causes of lymphadenopathy and perform full workup.
OMM / COMLEX integration
🦴
High-Yield Viscerosomatics, Autonomics & COMAT Shelf Clinical Pearls:
- Spleen & Reticuloendothelial Innervation (T5–T9): The spleen and bone marrow microvasculature are influenced by sympathetic outflow from the celiac plexus (T5–T9, left side). Somatic dysfunction at the mid-thoracic paraspinal levels reflects splenic hematologic stress.
- Lymphatic Return in Malignancy & Lymphedema: Post-surgical or post-radiation lymphedema requires gentle proximal-to-distal decongestion starting with opening the thoracic inlet and axillary fascial diaphragms before addressing peripheral extremities. Avoid vigorous direct pumping over known active tumor sites.
- Bone Marrow Pain & Myofascial Somatic Dysfunction: Patients with hematologic expansion or skeletal metastases develop reactive hypertonicity in surrounding postural stabilizers (quadratus lumborum, erector spinae). Gentle indirect techniques (counterstrain, myofascial release) provide substantial pain relief without risking pathologic fractures.